Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genscript
Pharma
Lilly-Innovent, Dizal, bispecific ADC—Fierce Pharma Asia
China approved a first-in-class weight loss drug. Dizal won FDA approval. Biokin's BMS-partnered bispecific ADC celebrates a phase 3 win.
Angus Liu
Jul 10, 2025 5:20pm
Merck and BioNTech's I-O bispecific buys—Fierce Pharma Asia
Nov 15, 2024 8:20am
GenScript sets up operations and logistics center in Australia
Nov 11, 2024 10:59am
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Oct 25, 2024 8:43am
Legend sheds GenScript as its majority shareholder
Oct 23, 2024 7:26am
J&J partner Legend Biotech reportedly receives buyout offer
Jul 15, 2024 11:06am